These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19216202)

  • 1. [Patency of foramen ovale in fullterm and preterm neonates. A follow-up study].
    Ghiglia S; Fesslovà V
    Pediatr Med Chir; 2008; 30(4):192-6. PubMed ID: 19216202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of echocardiographic characteristics and predictors for persistent defects of patent foramen ovale or patent ductus arteriosus in Chinese newborns.
    Yuan Z; Zhang LZ; Li B; Chung HT; Jiang JX; Chiang JY; Chiang HJ; Yip HK; Sung PH
    Biomed J; 2021 Apr; 44(2):209-216. PubMed ID: 33867286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of patent ductus arteriosus and patent foramen ovale on left ventricular stroke volume measurement by electrical velocimetry in comparison to transthoracic echocardiography in neonates.
    Blohm ME; Hartwich J; Obrecht D; Kersten JF; Singer D
    J Clin Monit Comput; 2017 Jun; 31(3):589-598. PubMed ID: 27072988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hemorrhage in extremely low birth weight infants: Significance of the size of left to right shunting through a valve incompetent patent foramen ovale.
    Kappico JM; Cayabyab R; Ebrahimi M; Uzunyan MY; Barton L; Siassi B; Ramanathan R
    J Perinatol; 2022 Sep; 42(9):1233-1237. PubMed ID: 35851183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
    Dani C; Bertini G; Corsini I; Elia S; Vangi V; Pratesi S; Rubaltelli FF
    Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent ductus arteriosus in African preterm infants.
    Musoke RN; Anabwani GA
    East Afr Med J; 1991 Aug; 68(8):637-41. PubMed ID: 1765017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
    Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience.
    Mangieri A; Godino C; Montorfano M; Arioli F; Rosa I; Ajello S; Piraino D; Monello A; Pavon AG; Viani G; Magni V; Cappelletti A; Margonato A; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):105-12. PubMed ID: 25382155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doppler echocardiographic investigation of left ventricular diastolic function in preterm infants with and without a patent ductus arteriosus].
    Schmitz L; Stiller B; Koehne P; Koch H; Lange PE
    Klin Padiatr; 2004; 216(1):36-40. PubMed ID: 14747970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
    Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
    Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
    Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell AR; Wilson N; Ormerod OJ
    Int J Cardiol; 2009 Jan; 131(3):438-40. PubMed ID: 18037512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of color Doppler echocardiographic findings in premature newborns with patent ductus arteriosus.
    Shen CT; Kua KE; Wang NK
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):104-10. PubMed ID: 9151462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.